Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;37(8):701-708.
doi: 10.1007/s40618-014-0091-8. Epub 2014 May 23.

Effects of cocaine on the hypothalamic-pituitary-adrenal axis

Affiliations
Review

Effects of cocaine on the hypothalamic-pituitary-adrenal axis

L Manetti et al. J Endocrinol Invest. 2014 Aug.

Abstract

Introduction: Cocaine hydrochloride is a psychoactive substance extracted from the leaves of plants called Erythroxylum coca. Cocaine is the second most commonly used drug in the world after cannabis; 20 % of cocaine users will become long-term cocaine-dependent patients. Different routes of administration may be recognized: smokable modality, intranasal and intravenous. Cocaine is a potent stimulant of the sympathetic nervous system and causes structural changes on the brain, heart, lung, liver and kidney. It has long been known that use of cocaine may produce alterations to the endocrine system. Research on behavioral and neuroendocrine effects of cocaine dates back several years ago and has increasingly focused on alterations of the hypothalamic-pituitary-adrenal (HPA) axis, which appears to be the chief target of cocaine effects.

Studies: Animal (mainly rats and monkeys) and human studies have clearly shown a close relation between cocaine consumption and overdrive of the HPA axis. Such activation is likely involved, though via a still undefined mechanism, in the behavioral and cardiovascular changes of drug abusers as well as in the reinforcement/relapse phenomena. Further studies of the pathophysiology of cocaine addicts will help to devise new therapeutic strategies for these patients.

PubMed Disclaimer

References

    1. J Clin Invest. 1997 Feb 15;99(4):628-34 - PubMed
    1. Brain Res. 2006 Dec 18;1126(1):200-3 - PubMed
    1. Psychoneuroendocrinology. 1997 May;22(4):237-59 - PubMed
    1. Br J Clin Pharmacol. 2010 May;69(5):427-42 - PubMed
    1. J Pharmacol Exp Ther. 1991 Nov;259(2):495-500 - PubMed

MeSH terms

LinkOut - more resources